Please login to the form below
Q4
This page shows the latest Q4 news and features for those working in and with pharma, biotech and healthcare.
European MPs call for urgent action against antimicrobial resistance
Against the backdrop of the revision of the Pharmaceutical Legislation and the planned European Council Recommendations on AMR taking place in Q4 2022, the event brought together high-level European policymakers
Latest news
-
Real-world data highlights flu vaccine efficacy
The study, which will begin in Q4 2021, will build on the Drive Beyond the Needle collaboration between Enesi and the Biomedical Advanced Research and Development Authority (BARDA) earlier this year,
-
US orders 1.4 million more doses of Regeneron antibody cocktail
Regeneron will start to ship the extra doses immediately with the vast majority will be delivered in Q4.
-
CureVac to push ahead with first- and second-generation COVID-19 vaccines
The biotech will seek EMA approval for first-generation jab while trials are due to start for second-generation jabs in Q4.
-
EU announces ‘top-up’ of ten million Pfizer/BioNTech vaccines in Q2
initially allocated for Q3 and Q4 of 2021, and would be brought forward.
-
bluebird bio posts modest Q4 revenue growth as it continues investigation into troubled LentiGlobin
bluebird bio has posted a modest increase in its Q4 revenues and has also provided an update about its clinical hold on its sickle cell disease gene therapy LentiGlobin.
More from news
Approximately 18 fully matching, plus 120 partially matching documents found.
Latest Intelligence
-
Congress 2020 BC (before COVID-19)
Taking a look at the Navigator365 ‘time- trends’ (EU5 SPEC, 2019 vs Q4 2020) we see that the online congress increased its reach by 37% (how often a physician has used
-
Industry needs an aligned position on the future of the EU OMP Regulation
By Emma Eatwell
-
Case study: Liver disease burden
Yet, in Q4 2013, the coalition government announced that the yet to be launched National Liver Strategy was being scrapped.
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest appointments
-
Novocure’s chief commercial officer to step down
clinical data in Q4 2014.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
EU Pharmaceutical Strategy Roadmap
EU Pharmaceutical Strategy. But what does this mean and what can we expect to be included in the strategy that is anticipated for late Q4 2020 or early 2021?
-
Porterhouse Medical launches new website showcasing the latest exciting developments within the group.
both of which were established in Q4 2017.
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Roche’s Polivy recommended by NICE for lymphoma therapy
- Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
- ASH 2022: bad blood but big advances
- AbbVie’s Rinvoq approved by MHRA for Crohn's disease
- GSK’s Benlysta given orphan drug status by FDA for systemic sclerosis
- AstraZeneca’s Imfinzi plus chemotherapy approved by MHRA for biliary tract cancer
- ICR calls for improved biomarker cancer tests to help personalise treatment
- EIT Health marks World Cancer Day with €6m pledge for new healthcare delivery models
- World Cancer Day: encouraging men to put their health first
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Strategic behaviour
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Creabilis names Catherine Moukheibir as chairman of the board
- World Health Organization releases latest set of COVID-19 guidelines
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- MIT researchers develop AI model to detect future lung cancer risk
PMHub
Research Partnership
Research Partnership, an Inizio Advisory Company, is a world-leading custom and syndicated global insights partner for health and life science...
Latest intelligence
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
- Strategic behaviour
- Strong strategising depends on your colleagues’ behaviour...
- Pharmaceutical Marketing Strategies For The Digital Age
- In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...
